Bharat Biotech vaccine

Bharat Biotech Intranasal Booster Dose Trials to Begin

Jan 29, 2022

The Drugs Controller General of India (DCGI) gave Hyderabad-based vaccine manufacturer Bharat Biotech permission to undertake clinical studies for its intranasal Covid booster dosage in India on...

Videos

What Are The Main Challenges In India’s Real Estate Sector? | NAR India 2019

August 30, 2019

You are here

Bharat Biotech vaccine

Bharat Biotech Intranasal Booster Dose Trials to Begin

Bury the False Propaganda of the Betrayal Coalition: Sajjala

What Are The Main Challenges In India’s Real Estate Sector? | NAR India 2019

What Are The Main Challenges In India’s Real Estate Sector? | NAR India 2019